Paper
2 April 1996 Photodynamic drug detection system for measurement of drug uptake
Winston Ho, Peter W. Low, Kalin Spariosu
Author Affiliations +
Abstract
It is known that if the drug uptake by a tumor is below the required concentration the efficacy of PDT can be significantly reduced. There is, therefore, a need for a photodynamic drug detection (PD3) system to be used with PDT to monitor the drug concentration in tissue in real time and noninvasively. The system developed integrates laser, a fiber optic probe, and an optical detector to detect photodynamic drugs (Photofrin II, Protoporphyrin IX, and BPD). A series of drug concentrations was measured based on the detection of diffusely fluorescence photons. The fluorescence peak at 680 nm is suggested for intensity measurement. The effect of fluorescence reabsorption was observed when using high concentration Photofrin solutions. When PD3 is used in conjunction with monitoring through an endoscope, the system offers spectral information (displayed on a computer monitor) in addition to the conventional image (displayed on an endoscope monitor).
© (1996) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Winston Ho, Peter W. Low, and Kalin Spariosu "Photodynamic drug detection system for measurement of drug uptake", Proc. SPIE 2675, Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy V, (2 April 1996); https://doi.org/10.1117/12.237524
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Luminescence

Tissue optics

Photodynamic therapy

Tissues

Tumors

Photons

Optical filters

Back to Top